Dannielle Appelhans serves as Executive at Rubius Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Dannielle Appelhans has executed 8 insider transactions totaling $39.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 8, 2023 involved purchasing 7,363 shares valued at $13.2K.
Dannielle Appelhans currently holds 7,363 shares of Rubius Therapeutics, Inc. (RUBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dannielle Appelhans has been a net buyer of RUBY stock. They have purchased $32.3K and sold $6.9K worth of shares.
Dannielle Appelhans's most recent insider trade was on Dec 8, 2023, when they purchased 7,363 shares at $1.79 per share.
Get notified when new Form 4 filings are submitted
| $1.82 |
| Discretionary |
| Dec 4, 2023 | GBIO | $18.0K | Purchase | 12,000 | $1.50 | Discretionary |
| Feb 24, 2023 | RUBY | $1.4K | Sale | 10,385 | $0.13 | Discretionary |
| Feb 1, 2023 | RUBY | $970 | Sale | 3,878 | $0.25 | Discretionary |
| Jan 31, 2023 | RUBY | $0 | Option Exercise | 7,500 | $N/A | Discretionary |
| Aug 10, 2022 | RUBY | $4.6K | Sale | 5,737 | $0.80 | Discretionary |
| Aug 9, 2022 | RUBY | $0 | Option Exercise | 12,500 | $N/A | Discretionary |